Immunotherapy News and Research

Latest Immunotherapy News and Research

BHF announces shortlist of four CVD research projects competing for £30 million award

The British Heart Foundation (BHF) today announced its shortlist of four research projects competing for a single £30 million award.

23 Jan 2020

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

22 Jan 2020

Discovery of potent immune cell that can destroy multiple types of cancer

The immune system is the body’s defense against harmful pathogens that may enter the body. Immune cells, such as white blood cells and macrophages work hand in hand to fight off disease-causing microorganisms, including cancer.

21 Jan 2020

Patient-specific tumor organoids may one day be used to personalize cancer treatment

A patient-specific tumor organoid platform developed by Wake Forest Institute for Regenerative Medicine researchers and their cancer center colleagues could someday take the guessing game out of immunotherapy treatments.

21 Jan 2020

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.

21 Jan 2020

Steer clear of allergy triggers when buying gifts for Valentine’s Day

Valentine's Day tends to bring out the urge to "spend big" on gifts that will sweep your loved one off their feet. But some gifts can cause allergy and asthma symptoms and should be avoided no matter how much you think they might convey your devotion.

21 Jan 2020

New technique accurately predicts which melanomas are likely to recur and spread

For most patients, melanoma begins with a small, pigmented spot on their skin that they notice starts to change.

20 Jan 2020

New melanoma test may better predict recurrence and improve patient care

Researchers at Brigham and Women's Hospital have developed a new technique that improves on the current method for assessing whether primary melanoma is likely to recur and spread, following surgical removal.

20 Jan 2020

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

One way to tackle cancer, the second-leading cause of death in the United States, is to target oncogenes -- genes that have the potential to cause cancer.

17 Jan 2020

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

It is known that the tumor microenvironment plays an important role in the progression of cancer. But could estrogen present in this microenvironment facilitate the growth of liver metastases in women affected by colon, pancreatic and lung cancers?

17 Jan 2020

Scientists discover how B-cells in tumor cells promote a favorable immunotherapy response

The white blood cells are potent fighters that protect the body against foreign invaders, including pathogens and cancer cells. Scientists have found that the presence of B cells, which are powerhouses, in tumor cells, combat the disease from within.

16 Jan 2020

Study sheds light on the role of B cells in cancer immunotherapy

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden.

16 Jan 2020

B cell count tells how certain cancers will respond to immunotherapy

Some melanomas, sarcomas and renal cell carcinomas, but not all, have been found to respond dramatically to new drugs called immune checkpoint blockers, which exploit the body’s known capability to mount an immune response against the foreign antigen-bearing tumor cells.

15 Jan 2020

Immune system contribution to tumor heterogeneity may influence liver cancer growth

Researchers at Mount Sinai School of Medicine say the immune system might contribute to the tumor heterogeneity seen in liver cancer that can affect the rate of cancer growth.

15 Jan 2020

InDepth Pharmaceuticals to commercialize novel technique to predict kidney transplant success

InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.

14 Jan 2020

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer.

14 Jan 2020

NUS researchers discover new personalized tool for cancer diagnosis

A team of researchers from the National University of Singapore has discovered a new personalized tool to detect cancer, predict patient survivability and how well a cancer patient would respond to immunotherapy.

14 Jan 2020

Researchers identify how marijuana accelerates growth of HPV-related head and neck cancer

University of California San Diego School of Medicine researchers have identified the molecular mechanism activated by the presence of tetrahydrocannabinol (THC) - the ingredient that causes people to feel the euphoria or "high" associated with cannabis - in the bloodstream that accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.

13 Jan 2020

Nano-sized copper compounds together with immunotherapy can kill cancer cells

An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.

9 Jan 2020

United States sees unprecedented fall in deaths from cancer

The death rate from cancer in the US has seen the greatest fall from 2016-2017 since rates started to fall in 1992 says the ACS.

9 Jan 2020

Immunotherapy News and Research

Latest Immunotherapy News and Research

BHF announces shortlist of four CVD research projects competing for £30 million award

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Discovery of potent immune cell that can destroy multiple types of cancer

Patient-specific tumor organoids may one day be used to personalize cancer treatment

Discovery of new killer T-cell offers hope of a 'one-size-fits-all' cancer therapy

Steer clear of allergy triggers when buying gifts for Valentine’s Day

New technique accurately predicts which melanomas are likely to recur and spread

New melanoma test may better predict recurrence and improve patient care

UCR receives $2.2 million grant to target critical oncogenes of B-cell lymphoma 2

Estrogen plays a role in expansion of liver metastases in non-sex-specific cancers

Scientists discover how B-cells in tumor cells promote a favorable immunotherapy response

Study sheds light on the role of B cells in cancer immunotherapy

B cell count tells how certain cancers will respond to immunotherapy

Immune system contribution to tumor heterogeneity may influence liver cancer growth

InDepth Pharmaceuticals to commercialize novel technique to predict kidney transplant success

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

NUS researchers discover new personalized tool for cancer diagnosis

Researchers identify how marijuana accelerates growth of HPV-related head and neck cancer

Nano-sized copper compounds together with immunotherapy can kill cancer cells

United States sees unprecedented fall in deaths from cancer

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in